Ampicillin
Brand names: Penbritin
Ampicillin is a broad-spectrum aminopenicillin antibiotic used for susceptible infections including certain respiratory, urinary, gastrointestinal and listerial infections.
Adult dose
Paediatric dose
Dose adjustments
In severe renal impairment (creatinine clearance <10 ml/min) a reduction in dose or extension of dose interval should be considered. In dialysis, give an additional dose after the procedure.
Dose auto-extracted from UK Summary of Product Characteristics (SPC) via the eMC; US FDA prescribing information (openFDA / DailyMed) — cross-check; US labelling may differ from UK — not yet clinician-verified. Always confirm against the product SmPC and your local formulary before prescribing.
UK SPC: for meningitis, children's dosage is 150 mg/kg daily IV in divided doses. General paediatric guidance: half adult routine dosage for children under 10 years. All dosages are a guide only and may be increased in severe infections. (Note: US FDA fallback label is for ampicillin/sulbactam combination — 300 mg/kg/day of the combination in children ≥1 year — not directly comparable to ampicillin alone.) Verify against a children's formulary.
Contraindications
- Hypersensitivity to the active substance or to any of the excipients
- History of hypersensitivity to beta-lactam antibiotics (e.g. ampicillin, penicillins, cephalosporins)
Side effects
- Skin rash, pruritus and urticaria (occasional; higher incidence in infectious mononucleosis and lymphoid leukaemia)
- Nausea, vomiting and diarrhoea
- Anaphylaxis (rare)
- Interstitial nephritis (rare)
- Haematological effects — transient leucopenia, thrombocytopenia and haemolytic anaemia (rare)
Interactions
- Aminoglycosides — do not mix in the same syringe/IV container/giving set; loss of aminoglycoside activity can occur
- Bacteriostatic drugs — may interfere with the bactericidal action of ampicillin
- Oral contraceptives — ampicillin may reduce their efficacy; warn patients
- Probenecid — decreases renal tubular secretion of ampicillin, increasing and prolonging blood levels
- Allopurinol — concurrent use can increase the likelihood of allergic skin reactions
Clinical monograph
How it works
It inhibits bacterial cell wall synthesis by binding penicillin-binding proteins, leading to bacterial lysis.
Prescribing in practice
- It is contraindicated in patients with penicillin hypersensitivity, who are at risk of anaphylaxis.
- A maculopapular rash is common if given in glandular fever (infectious mononucleosis) and it should be avoided in this setting.
- Many common organisms produce beta-lactamases conferring resistance, so therapy should be guided by susceptibility where possible.
Monitoring
Monitor for hypersensitivity reactions and clinical response, and review renal and hepatic function with prolonged or high-exposure treatment.
Counselling the patient
- Report any rash, swelling or breathing difficulty, which may indicate allergy.
- Complete the full prescribed course even if you feel better.
- Tell your prescriber if you have ever reacted to a penicillin.
Evidence & guidelines
Ampicillin and related aminopenicillins are long-established agents with well-defined roles in UK antimicrobial guidance.
Reference: BSAC Endocarditis Guidelines (2012 updated); NICE NG51 (Meningitis); PHE/UKHSA antibiotic guidelines; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. The structured dose values shown have been reviewed by a clinician. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Centor / McIsaac Score for Strep Pharyngitis · Throat
- FeverPAIN Score for Strep Throat · Throat
- Jarisch-Herxheimer Reaction Severity Assessment · Treatment Reactions
- PID Severity (CDC Diagnostic Criteria) · Gynaecological Infections
- Gustilo-Anderson Classification (Open Fractures) · Fracture Classification
- DRIP Score for Drug-Resistant Pneumonia · Pneumonia
- Infective Endocarditis · ESC 2023 Infective Endocarditis Guidelines; NICE NG41
- Eczema Herpeticum · BAD; NICE CKS
- Suspected Bacterial Meningitis (Adult) · NICE NG240 (2024); NICE NG143 (paeds)
- Clostridioides difficile Colitis · NICE NG199 (2021); IDSA/SHEA 2021
- Returning Traveller — Fever · NaTHNaC; PHE; ESCMID 2018
- Malaria — Diagnosis & Management · PHE 2016; WHO 2023